ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 32 filers reported holding ASLAN PHARMACEUTICALS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,000 | +28.6% | 14,200 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | -46.2% | 14,200 | 0.0% | 0.00% | – |
| Q1 2022 | $13,000 | -77.2% | 14,200 | -71.9% | 0.00% | -100.0% |
| Q4 2021 | $57,000 | -36.7% | 50,500 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $90,000 | -45.5% | 50,500 | +1.0% | 0.00% | -42.9% |
| Q2 2021 | $165,000 | -1.8% | 50,000 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $168,000 | – | 50,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,017,971 | $2,066,000 | 0.49% |
| DAFNA Capital Management LLC | 117,682 | $239,000 | 0.08% |
| Temasek Holdings (Private) Ltd | 1,422,475 | $2,888,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 415,450 | $843,000 | 0.02% |
| Virtu Financial LLC | 54,386 | $110,000 | 0.01% |
| MARSHALL WACE, LLP | 96,095 | $195,000 | 0.00% |
| UBS Group AG | 150 | $0 | 0.00% |
| DEUTSCHE BANK AG\ | 2,151 | $4,000 | 0.00% |
| MORGAN STANLEY | 18,582 | $37,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 10,000 | $20,000 | 0.00% |